NASDAQ$WOOF
Petco Health & Wellness Company Inc · Q4 2024 earnings
Q4 2024 earnings · · After market close · Investor relations
Briefing
Petco Health and Wellness reported Q4 2024 revenue of $1.60B, a net loss of $13.8M, diluted EPS of $-0.05.
For Q4 2024, Petco Health and Wellness reported Revenue was $1.60B, net loss was $13.8M, diluted EPS was $-0.05. Management discusses segment trends, liquidity, and outlook in the quarterly filing.
- Revenue $1.60B for Q4 2024.
- Net loss $13.8M.
- Diluted EPS $-0.05.
Headline financials
Revenue & EPS history
Petco · Revenue · Quarterly
$1.6B
Revenue by segment
Petco · $1.49B total across 2 segments · Q1 2025
- Products$1.24B—83.2%
- Services and other$252M—16.8%
Forward guidance
Outlook emphasizes clinical milestones, liquidity runway, and operating expense discipline.
Tailwinds
- Pipeline progress and partnership economics.
- Cash supports near-term operating plans.
Headwinds
- Operating losses until commercial scale.
- Financing and trial outcomes affect funding costs.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q4 2024
+4.4%
Avg return
Earnings day
+3.6%
Avg return
5 days after
+1.2%
Avg return
30 days after
55%
12 / 22 earnings
Positive
+43.2%
Q2 2024
Best reaction
-21.4%
Q3 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -6.2% | -10.8% | — | |
| Q4 2025 | +34.0% | +40.8% | +16.2% | |
| Q3 2025 | +13.9% | +2.4% | -1.3% | |
| Q2 2025 | +23.5% | +2.5% | +8.4% | |
| Q1 2025 | +4.4% | +4.1% | -1.0% | |
| Q4 2024 | +31.6% | +21.3% | +26.6% | |
| Q3 2024 | +4.8% | -9.8% | -19.6% | |
| Q2 2024 | +43.2% | +60.7% | +78.2% | |
| Q1 2024 | +29.4% | +46.1% | +44.5% | |
| Q4 2023 | -19.5% | -21.5% | -32.8% | |
| Q3 2023 | -21.4% | -5.7% | -17.7% | |
| Q2 2023 | -17.1% | -17.3% | -40.2% | |
| Q1 2023 | -20.8% | -21.2% | -13.9% | |
| Q4 2022 | -20.4% | -21.1% | -4.8% | |
| Q3 2022 | +16.9% | +15.7% | -0.1% | |
| Q2 2022 | -3.2% | -4.6% | -23.9% | |
| Q1 2022 | +5.1% | +12.7% | +12.3% | |
| Q4 2021 | +8.1% | +4.2% | +13.9% | |
| Q3 2021 | -15.5% | -17.5% | -19.0% | |
| Q2 2021 | +11.6% | +12.0% | +16.5% | |
| Q1 2021 | -4.0% | -6.6% | -13.5% | |
| Q4 2020 | -0.9% | -6.1% | -3.1% | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q4 2019 | — | — | — | |
| Q3 2019 | — | — | — | |
| Q2 2019 | — | — | — | |
| Q1 2020 | — | — | — | |
| Q2 2017 | — | — | — | |
| Q1 2017 | — | — | — | |
| Q4 2016 | — | — | — | |
| Q3 2016 | — | — | — | |
| Q2 2016 | — | — | — | |
| Q1 2016 | — | — | — | |
| Q4 2015 | — | — | — | |
| Q3 2015 | — | — | — | |
| Q2 2015 | — | — | — | |
| Q1 2015 | — | — | — | |
| Q4 2014 | — | — | — | |
| Q3 2014 | — | — | — | |
| Q2 2014 | — | — | — | |
| Q1 2014 | — | — | — | |
| Q4 2013 | — | — | — | |
| Q3 2013 | — | — | — | |
| Q2 2013 | — | — | — | |
| Q1 2013 | — | — | — | |
| Q4 2012 | — | — | — | |
| Q3 2012 | — | — | — | |
| Q2 2012 | — | — | — | |
| Q1 2012 | — | — | — | |
| Q4 2011 | — | — | — | |
| Q3 2011 | — | — | — | |
| Q2 2011 | — | — | — | |
| Q1 2011 | — | — | — | |
| Q4 2010 | — | — | — | |
| Q3 2010 | — | — | — | |
| Q2 2010 | — | — | — | |
| Q1 2010 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro